These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 9020082)

  • 1. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis.
    Sattler M; Liang H; Nettesheim D; Meadows RP; Harlan JE; Eberstadt M; Yoon HS; Shuker SB; Chang BS; Minn AJ; Thompson CB; Fesik SW
    Science; 1997 Feb; 275(5302):983-6. PubMed ID: 9020082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
    Lama D; Sankararamakrishnan R
    Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural biology of the Bcl-2 family of proteins.
    Petros AM; Olejniczak ET; Fesik SW
    Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.
    Ottilie S; Diaz JL; Horne W; Chang J; Wang Y; Wilson G; Chang S; Weeks S; Fritz LC; Oltersdorf T
    J Biol Chem; 1997 Dec; 272(49):30866-72. PubMed ID: 9388232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.
    Moroy G; Martin E; Dejaegere A; Stote RH
    J Biol Chem; 2009 Jun; 284(26):17499-511. PubMed ID: 19293158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and application of an alpha-helix-mimetic scaffold based on an oligoamide-foldamer strategy: antagonism of the Bak BH3/Bcl-xL complex.
    Ernst JT; Becerril J; Park HS; Yin H; Hamilton AD
    Angew Chem Int Ed Engl; 2003 Feb; 42(5):535-9. PubMed ID: 12569483
    [No Abstract]   [Full Text] [Related]  

  • 7. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members.
    Diaz JL; Oltersdorf T; Horne W; McConnell M; Wilson G; Weeks S; Garcia T; Fritz LC
    J Biol Chem; 1997 Apr; 272(17):11350-5. PubMed ID: 9111042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
    Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
    J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
    Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
    Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
    Huang DC; Adams JM; Cory S
    EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
    Rajan S; Choi M; Baek K; Yoon HS
    Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL.
    Degterev A; Lugovskoy A; Cardone M; Mulley B; Wagner G; Mitchison T; Yuan J
    Nat Cell Biol; 2001 Feb; 3(2):173-82. PubMed ID: 11175750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions.
    Chittenden T; Flemington C; Houghton AB; Ebb RG; Gallo GJ; Elangovan B; Chinnadurai G; Lutz RJ
    EMBO J; 1995 Nov; 14(22):5589-96. PubMed ID: 8521816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-xl does not have to bind Bax to protect T cells from death.
    Liu X; Zhu Y; Dai S; White J; Peyerl F; Kappler JW; Marrack P
    J Exp Med; 2006 Dec; 203(13):2953-61. PubMed ID: 17158961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bak can accelerate chemotherapy-induced cell death independently of its heterodimerization with Bcl-XL and Bcl-2.
    Simonian PL; Grillot DA; Nuñez G
    Oncogene; 1997 Oct; 15(15):1871-5. PubMed ID: 9362454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
    Modi V; Lama D; Sankararamakrishnan R
    J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM; Sborgi L; de Alba E
    J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the anti-apoptotic mechanism of Bcl-B.
    Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
    Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.
    Muchmore SW; Sattler M; Liang H; Meadows RP; Harlan JE; Yoon HS; Nettesheim D; Chang BS; Thompson CB; Wong SL; Ng SL; Fesik SW
    Nature; 1996 May; 381(6580):335-41. PubMed ID: 8692274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein.
    Yin H; Hamilton AD
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1375-9. PubMed ID: 15006365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.